6-K 1 form6-kxunityfdaapproval20.htm 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 6-K

_________________

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

June 24, 2024

Commission File Number: 001-31269

_________________

 

 

ALCON INC.

(Registrant Name)

Rue Louis-d'Affry 6
1701, Fribourg, Switzerland

(Address of principal executive office)

_________________

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40-F: Form 20-F ☒     Form 40-F ☐

---

EXHIBIT INDEX

Exhibit Number						Description
99.1						Press release issued by Alcon Inc. dated June 24, 2024 titled “Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance”

2

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

ALCON INC.

Date:

June 24, 2024

By:

/s/ Royce Bedward

Name: Royce Bedward

Title: Authorized Representative

Date:

June 24, 2024

By:

/s/ Ian Bell

Name: Ian Bell

Title: Authorized Representative

3